Bayer AG (BAYZF)
43.30
-1.90
(-4.21%)
USD |
OTCM |
Apr 28, 16:00
Bayer EPS Diluted (Quarterly) : -4.451 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| MediGene AG | -- |
| InflaRx NV | -0.2115 |
| BioNTech SE | -1.448 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.365B |
| Revenue (Quarterly) | 13.31B |
| Total Expenses (Quarterly) | 17.69B |
| Enterprise Value | 77.42B |
| Gross Profit Margin (Quarterly) | 60.65% |
| Profit Margin (Quarterly) | -32.79% |
| Earnings Yield | -10.24% |
| Operating Earnings Yield | 18.02% |
| Normalized Earnings Yield | 1.632 |